Population-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount Program

Farris, Karen B.; Ganther-Urmie, Julie M.; Fang, Gang; Doucette, William R.; Brooks, John M.; Klepser, Donald G.; Fries, David J.; Kuhle, Carol L.

doi:10.1345/aph.1e204

Cited by 23 publications

(27 citation statements)

References 18 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A number of studies have demonstrated that the elderly are at a greater risk of experiencing drug-related problems (DRPs) compared to the remainder of the population [2][3][4]. This is due to numerous factors, including changes in pharmacodynamics and pharmacokinetics, a higher incidence of multiple chronic diseases, polypharmacy and reduced cognitive capacity.…”

mentioning

confidence: 99%

Drug-related problems identified in medication reviews by Australian pharmacists

et al. 2009

View full text Add to dashboard Cite

These data illustrate the prevalence of drug-related problems and the ability of pharmacists to identify these problems in the Australian models of medication review. The nature and frequency of problems varied between reviews for home-dwelling and care-facility patients. Such information may be used to better focus the training of practitioners based on the most frequently encountered health problems and the nature of common drug-related problems in the two settings.

show abstract

mentioning

confidence: 99%

Drug-related problems identified in medication reviews by Australian pharmacists

et al. 2009

View full text Add to dashboard Cite

show abstract

“…This finding could be the result of patients’ approaching the pharmacist for another MCA after a positive prior experience. In a US study 24 % of individuals who had received a medication review (brown bag review) responded positively when asked if they would have a review annually [28]. In addition, from a pharmacist’s perspective, experienced MCA users may be easy to identify through the pharmacy’s patient profile system, and engage since they have responded positively to MCA in the past.…”

Section: Discussionmentioning

confidence: 99%

Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario

Pechlivanoglou

Abrahamyan

MacKeigan

et al. 2016

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundMedication reviews have become part of pharmacy practice across developed countries. This study aimed to identify factors affecting the likelihood of eligible Ontario seniors receiving a pharmacy-led medication review called MedsCheck annual (MCA).MethodsWe designed a cohort study using a random sample of pharmacy claims for MCA-eligible Ontario seniors using linked administrative data from April 2012 to March 2013. Guided by a conceptual framework, we constructed a generalized-estimating-equations model to estimate the effect of patient, pharmacy and community factors on the likelihood of receiving MCA.ResultsOf the 2,878,958 eligible claim-dates, 65,605 included an MCA. Compared to eligible individuals who did not receive an MCA, recipients were more likely to have a prior MCA (OR = 3.03), receive a new medication on the claim-date (OR = 1.78), be hypertensive (OR = 1.18) or have a recent hospitalization (OR = 1.07). MCA recipients had fewer medications (e.g., OR = 0.44 for ≥12 medications versus 0–4 medications), and were less likely to receive an MCA in a rural (OR = 0.74) or high-volume pharmacy (OR = 0.65).ConclusionsThe most important determinant of receiving an MCA was having had a prior MCA. Overall, MCA recipients were healthier, younger, urban-dwelling, and taking fewer medications than non-recipients. Policies regarding current and future medication review programs may need to evolve to ensure that those at greatest need receive timely and comprehensive medication reviews.

show abstract

“…A recent study 15 found that this approach is cost-effective, promoting changes in medication regimen and encouraging pharmacist/ physician dialogue. The medication review can be viewed as an enhanced service that is commissioned by each primary care organization.…”

mentioning

confidence: 99%

Medication review for the older person

Banning

2007

Rev. Clin. Gerontol.

View full text Add to dashboard Cite

People of 65 years and older accounted for 21% of the population of England and Wales in 2001, and their proportion is increasing. It is forecast that the number of people over the age 75 years will double within the next 50 years, and that of those over the age of 90 will increase fivefold. The older patient with declining health poses significant challenges for health care professionals, in particular those of managing chronic morbidity and the effects of aging. Many older people require pharmacological treatment for multiple, co-existing pathologies. Those of 65 years and over receive 56% of all prescriptions in England, of which 78% are repeat prescriptions, and people in residential care, on average, receive five different medicines concurrently. The impact of repeat prescriptions means that, due to inadequate monitoring, many older people continue to administer medicines they no longer require, and thereby risk receiving an inappropriate drug, dose or duration of treatment. In addition to this, there is the propensity for older people to mismanage medicines, increasing their risk of unplanned drug-related admission to hospital and drug-related morbidity.

show abstract

Population-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount Program

Cited by 23 publications

References 18 publications

Drug-related problems identified in medication reviews by Australian pharmacists

Drug-related problems identified in medication reviews by Australian pharmacists

Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario

Medication review for the older person

Contact Info

Product

Resources

About